Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Small Cell Lung Carcinoma 3Retinoblastoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Meningeal Carcinomatosis 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Carcinoma, Ovarian Epithelial 1Burkitt Lymphoma 1

Interventions

Cytarabine 29Busulfan 12Filgrastim 10Daunorubicin 10Peripheral Blood Stem Cell Transplantation 9Idarubicin 9Mitoxantrone 8Methotrexate 8Etoposide 8Cyclosporine 8Gemtuzumab 7Cyclophosphamide 7sargramostim 6fludarabine phosphate 6Azacitidine 6Antilymphocyte Serum 6Decitabine 5tipifarnib 4alvocidib 4Tacrolimus 4Injections 4Cyclosporins 4Biopsy 4Whole-Body Irradiation 3Vorinostat 3Radiotherapy 3Mycophenolic Acid 3Flow Cytometry 3Cytogenetic Analysis 3Clofarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Monocytic, Acute × trioctyl phosphine oxide × Clear all
NCT00634244 2015-07-07

Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
92 enrolled 10 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡